To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Doxil or Doxorubicin to be administered was administered in a dose of 50 mg/m2 as infusion
over 15 minutes. Blood samples to be obtained at 0, 1, 2, 3, 4, 8, 12, 24, 48 and 72 hours